Identification of Phytochemicals in Bioactive Extracts of Acacia saligna Growing in Australia.
- Publisher:
- MDPI
- Publication Type:
- Journal Article
- Citation:
- Molecules, 2023, 28, (3), pp. 1028
- Issue Date:
- 2023-01-19
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Asmara, AP | |
dc.contributor.author | Prasansuklab, A | |
dc.contributor.author | Tencomnao, T | |
dc.contributor.author | Ung, AT | |
dc.date.accessioned | 2023-12-05T04:16:17Z | |
dc.date.available | 2023-01-16 | |
dc.date.available | 2023-12-05T04:16:17Z | |
dc.date.issued | 2023-01-19 | |
dc.identifier.citation | Molecules, 2023, 28, (3), pp. 1028 | |
dc.identifier.issn | 1420-3049 | |
dc.identifier.issn | 1420-3049 | |
dc.identifier.uri | http://hdl.handle.net/10453/173691 | |
dc.description.abstract | Acacia saligna growing in Australia has not been fully investigated for its bioactive phytochemicals. Sequential polarity-based extraction was employed to provide four different extracts from individual parts of A. saligna. Bioactive extracts were determined using in vitro antioxidant and yeast α-glucosidase inhibitory assays. Methanolic extracts from barks, leaves, and flowers are the most active and have no toxicity against 3T3-L1 adipocytes. Compound isolation of bioactive extracts provided us with ten compounds. Among them are two novel natural products; naringenin-7-O-α-L-arabinopyranoside 2 and (3S*,5S*)-3-hydroxy-5-(2-aminoethyl) dihydrofuran-2(3H)-one 9. D-(+)-pinitol 5a (from barks and flowers), (-)-pinitol 5b (exclusively from leaf), and 2,4-di-t-butylphenol 7 are known natural products and new to A. saligna. (-)-Epicatechin 6, quercitrin 4, and myricitrin 8 showed potent antioxidant activities consistently in DPPH and ABTS assays. (-)-Epicatechin 6 (IC50 = 63.58 μM),D-(+)-pinitol 5a (IC50 = 74.69 μM), and naringenin 1 (IC50 = 89.71 μM) are the strong inhibitors against the α-glucosidase enzyme. The presence of these compounds supports the activities exerted in our methanolic extracts. The presence of 2,4-di-t-butylphenol 7 may support the reported allelopathic and antifungal activities. The outcome of this study indicates the potential of Australian A. saligna as a rich source of bioactive compounds for drug discovery targeting type 2 diabetes. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | MDPI | |
dc.relation.ispartof | Molecules | |
dc.relation.isbasedon | 10.3390/molecules28031028 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 0304 Medicinal and Biomolecular Chemistry, 0305 Organic Chemistry, 0307 Theoretical and Computational Chemistry | |
dc.subject.classification | Organic Chemistry | |
dc.subject.classification | 3404 Medicinal and biomolecular chemistry | |
dc.subject.classification | 3405 Organic chemistry | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Plant Extracts | |
dc.subject.mesh | Antioxidants | |
dc.subject.mesh | Acacia | |
dc.subject.mesh | Diabetes Mellitus, Type 2 | |
dc.subject.mesh | Catechin | |
dc.subject.mesh | alpha-Glucosidases | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Phytochemicals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Acacia | |
dc.subject.mesh | Diabetes Mellitus, Type 2 | |
dc.subject.mesh | Catechin | |
dc.subject.mesh | alpha-Glucosidases | |
dc.subject.mesh | Plant Extracts | |
dc.subject.mesh | Antioxidants | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Phytochemicals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Plant Extracts | |
dc.subject.mesh | Antioxidants | |
dc.subject.mesh | Acacia | |
dc.subject.mesh | Diabetes Mellitus, Type 2 | |
dc.subject.mesh | Catechin | |
dc.subject.mesh | alpha-Glucosidases | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Phytochemicals | |
dc.title | Identification of Phytochemicals in Bioactive Extracts of Acacia saligna Growing in Australia. | |
dc.type | Journal Article | |
utslib.citation.volume | 28 | |
utslib.location.activity | Switzerland | |
utslib.for | 0304 Medicinal and Biomolecular Chemistry | |
utslib.for | 0305 Organic Chemistry | |
utslib.for | 0307 Theoretical and Computational Chemistry | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Mathematical and Physical Sciences | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2023-12-05T04:16:03Z | |
pubs.issue | 3 | |
pubs.publication-status | Published online | |
pubs.volume | 28 | |
utslib.citation.issue | 3 |
Abstract:
Acacia saligna growing in Australia has not been fully investigated for its bioactive phytochemicals. Sequential polarity-based extraction was employed to provide four different extracts from individual parts of A. saligna. Bioactive extracts were determined using in vitro antioxidant and yeast α-glucosidase inhibitory assays. Methanolic extracts from barks, leaves, and flowers are the most active and have no toxicity against 3T3-L1 adipocytes. Compound isolation of bioactive extracts provided us with ten compounds. Among them are two novel natural products; naringenin-7-O-α-L-arabinopyranoside 2 and (3S*,5S*)-3-hydroxy-5-(2-aminoethyl) dihydrofuran-2(3H)-one 9. D-(+)-pinitol 5a (from barks and flowers), (-)-pinitol 5b (exclusively from leaf), and 2,4-di-t-butylphenol 7 are known natural products and new to A. saligna. (-)-Epicatechin 6, quercitrin 4, and myricitrin 8 showed potent antioxidant activities consistently in DPPH and ABTS assays. (-)-Epicatechin 6 (IC50 = 63.58 μM),D-(+)-pinitol 5a (IC50 = 74.69 μM), and naringenin 1 (IC50 = 89.71 μM) are the strong inhibitors against the α-glucosidase enzyme. The presence of these compounds supports the activities exerted in our methanolic extracts. The presence of 2,4-di-t-butylphenol 7 may support the reported allelopathic and antifungal activities. The outcome of this study indicates the potential of Australian A. saligna as a rich source of bioactive compounds for drug discovery targeting type 2 diabetes.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph